336 related articles for article (PubMed ID: 17522211)
1. Human immunodeficiency virus type 1 Vif inhibits packaging and antiviral activity of a degradation-resistant APOBEC3G variant.
Opi S; Kao S; Goila-Gaur R; Khan MA; Miyagi E; Takeuchi H; Strebel K
J Virol; 2007 Aug; 81(15):8236-46. PubMed ID: 17522211
[TBL] [Abstract][Full Text] [Related]
2. Monomeric APOBEC3G is catalytically active and has antiviral activity.
Opi S; Takeuchi H; Kao S; Khan MA; Miyagi E; Goila-Gaur R; Iwatani Y; Levin JG; Strebel K
J Virol; 2006 May; 80(10):4673-82. PubMed ID: 16641260
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions.
Khan MA; Goila-Gaur R; Opi S; Miyagi E; Takeuchi H; Kao S; Strebel K
Retrovirology; 2007 Jul; 4():48. PubMed ID: 17631688
[TBL] [Abstract][Full Text] [Related]
4. Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.
Liu B; Yu X; Luo K; Yu Y; Yu XF
J Virol; 2004 Feb; 78(4):2072-81. PubMed ID: 14747572
[TBL] [Abstract][Full Text] [Related]
5. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
Russell RA; Pathak VK
J Virol; 2007 Aug; 81(15):8201-10. PubMed ID: 17522216
[TBL] [Abstract][Full Text] [Related]
6. Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells.
Kao S; Miyagi E; Khan MA; Takeuchi H; Opi S; Goila-Gaur R; Strebel K
Retrovirology; 2004 Sep; 1():27. PubMed ID: 15373943
[TBL] [Abstract][Full Text] [Related]
7. Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation.
Huthoff H; Malim MH
J Virol; 2007 Apr; 81(8):3807-15. PubMed ID: 17267497
[TBL] [Abstract][Full Text] [Related]
8. Functional domains of APOBEC3G required for antiviral activity.
Li J; Potash MJ; Volsky DJ
J Cell Biochem; 2004 Jun; 92(3):560-72. PubMed ID: 15156567
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Vif promotes the formation of high molecular mass APOBEC3G complexes.
Goila-Gaur R; Khan MA; Miyagi E; Kao S; Opi S; Takeuchi H; Strebel K
Virology; 2008 Mar; 372(1):136-46. PubMed ID: 18023836
[TBL] [Abstract][Full Text] [Related]
10. Production of infectious virus and degradation of APOBEC3G are separable functional properties of human immunodeficiency virus type 1 Vif.
Kao S; Goila-Gaur R; Miyagi E; Khan MA; Opi S; Takeuchi H; Strebel K
Virology; 2007 Dec; 369(2):329-39. PubMed ID: 17825339
[TBL] [Abstract][Full Text] [Related]
11. Production of infectious SIVagm from human cells requires functional inactivation but not viral exclusion of human APOBEC3G.
Takeuchi H; Kao S; Miyagi E; Khan MA; Buckler-White A; Plishka R; Strebel K
J Biol Chem; 2005 Jan; 280(1):375-82. PubMed ID: 15528183
[TBL] [Abstract][Full Text] [Related]
12. Lentiviral Vif: viral hijacker of the ubiquitin-proteasome system.
Ehrlich ES; Yu XF
Int J Hematol; 2006 Apr; 83(3):208-12. PubMed ID: 16720549
[TBL] [Abstract][Full Text] [Related]
13. RNA and DNA binding properties of HIV-1 Vif protein: a fluorescence study.
Bernacchi S; Henriet S; Dumas P; Paillart JC; Marquet R
J Biol Chem; 2007 Sep; 282(36):26361-8. PubMed ID: 17609216
[TBL] [Abstract][Full Text] [Related]
14. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway.
Mehle A; Strack B; Ancuta P; Zhang C; McPike M; Gabuzda D
J Biol Chem; 2004 Feb; 279(9):7792-8. PubMed ID: 14672928
[TBL] [Abstract][Full Text] [Related]
15. Insights into the dual activity of SIVmac239 Vif against human and African green monkey APOBEC3G.
Gaur R; Strebel K
PLoS One; 2012; 7(11):e48850. PubMed ID: 23189135
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.
Stopak K; de Noronha C; Yonemoto W; Greene WC
Mol Cell; 2003 Sep; 12(3):591-601. PubMed ID: 14527406
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.
Shirakawa K; Takaori-Kondo A; Kobayashi M; Tomonaga M; Izumi T; Fukunaga K; Sasada A; Abudu A; Miyauchi Y; Akari H; Iwai K; Uchiyama T
Virology; 2006 Jan; 344(2):263-6. PubMed ID: 16303161
[TBL] [Abstract][Full Text] [Related]
18. Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.
Tian C; Yu X; Zhang W; Wang T; Xu R; Yu XF
J Virol; 2006 Mar; 80(6):3112-5. PubMed ID: 16501124
[TBL] [Abstract][Full Text] [Related]
19. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.
Sheehy AM; Gaddis NC; Malim MH
Nat Med; 2003 Nov; 9(11):1404-7. PubMed ID: 14528300
[TBL] [Abstract][Full Text] [Related]
20. New insights into the role of Vif in HIV-1 replication.
Schröfelbauer B; Yu Q; Landau NR
AIDS Rev; 2004; 6(1):34-9. PubMed ID: 15168739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
